The effect of dosage cards on compliance with directly observed tuberculosis therapy in hospital

International Journal of Tuberculosis and Lung Disease

Volumn 2, Issue 2, 1998, Pages 168-171

  Sonnenberg, P ^a   Ross, M H ^a   Shearer, S C P M ^b,d   Murray, J ^c  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b GOLD FIELDS LIMITED   (South Africa)

^c National Centre for Occupational Health   (South Africa)

^d MedGold   (South Africa)

Author keywords

Compliance; Directly observed therapy; Hospital; Tuberculosis

Indexed keywords

ISONIAZID; RIFAMPICIN;

ARTICLE; DOSE CALCULATION; HEALTH CARE COST; HUMAN; INFORMATION RETRIEVAL; MAJOR CLINICAL STUDY; MEDICAL RECORD; PATIENT COMPLIANCE; PATIENT EDUCATION; PRIORITY JOURNAL; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ANTITUBERCULAR AGENTS; DRUG THERAPY, COMBINATION; GOLD; HOSPITAL UNITS; HUMANS; INCIDENCE; MALE; MINING; PATIENT COMPLIANCE; SOUTH AFRICA; TIME FACTORS; TUBERCULOSIS, PULMONARY;

EID: 0031904924     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Sutherland I. The epidemiology of tuberculosis - is prevention better than cure? Bull Int Union Tuberc Lung Dis 1981; 56: 127-134.
2. China Tuberculosis Collaboration. Results of directly observed short-course chemotherapy in 112 842 Chinese patients with smear-positive tuberculosis. Lancet 1996; 347: 358-362.
3. Weis S E, Slocum P C, Blais F X, et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med 1994; 330: 1179-1184.
4. Chaulet P. Compliance with anti-tuberculous chemotherapy in developing countries. Tubercle 1987; 68: 19-24.
5. Fox W. Compliance of patients and physicians: experience and lessons in tuberculosis. BMJ 1983; 287: 33-35, 101-105.
6. Sumartojo E. When tuberculosis treatment fails. A social behavioral account of patient adherence. Am Rev Respir Dis 1993; 147: 1311-1320.
7. World Health Organization. WHO Tuberculosis Programme. Framework for effective tuberculosis control. Geneva: WHO, 1994.
8. Bayer R, Wilkinson D. Directly observed therapy for tuberculosis: history of an idea. Lancet 1995; 345: 1545-1548.
9. Burkhardt K R, Nel E E. Monitoring regularity of drug intake in tuberculous patients by means of simple urine tests. S Afr Med J 1980; 57: 981-985.
10. Gold Fields West Hospital. Annual Report 1995.
11. Eidus L, Hamilton E J. A new method for the determination of N-acetylisoniazid in urine of ambulatory patients. Am Rev Respir Dis 1964; 89: 587-588.
12. Pozsik C J. Compliance with tuberculosis therapy. Med Clin North Am 1993; 77: 1289-1301.
13. Fox W, Prabhakar R, Ganapathy S, Somasundaram P R. An enquiry into the attitudes of South Indian patients to the coloration of their urine by rifampicin. Tubercle 1987; 68: 201-207.
14. Iseman M D, Cohn D L, Sbarbaro J A. Directly observed treatment of tuberculosis: We can't afford not to try it. N Engl J Med 1993; 328: 576-578.
15. Morse D I. Directly observed therapy for tuberculosis. Spend now or pay later. BMJ 1996, 312: 719-720.